Showing results (191-200 of 2,355) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|August 1, 1996
A double-blind pharmacokinetic and clinical dose-response study of entacapone as an adjuvant to levodopa therapy in advanced Parkinson's diseaseH M Ruottinen, U K RinneClinical Neuropharmacology|August 1, 1996
Zolpidem in the treatment of short-term insomnia: a randomized, double-blind, placebo-controlled clinical trialR J Dockhorn, D W DockhornClinical Neuropharmacology|August 1, 1996
An open-label study of the therapeutic efficacy of high-dose famotidine adjuvant pharmacotherapy in schizophrenia: preliminary evidence for treatment efficacyR B Rosse, K Kendrick, M Fay-McCarthy, et al.Clinical Neuropharmacology|February 1, 1995
Weight loss in patients taking felbamateD C Bergen, R K Ristanovic, K Waicosky, et al.Clinical Neuropharmacology|February 1, 1995
Effect of entacapone, a COMT inhibitor, on the pharmacokinetics and metabolism of levodopa after administration of controlled-release levodopa-carbidopa in volunteersS Ahtila, S Kaakkola, A Gordin, et al.Clinical Neuropharmacology|October 1, 1995
Acute challenge with apomorphine in Huntington's disease: a double-blind studyA Albanese, E Cassetta, D Carretta, et al.Clinical Neuropharmacology|October 1, 1995
Color vision in Parkinson's disease: missing influence of amantadine sulphateT Büttner, W Kuhn, T Müller, et al.Clinical Neuropharmacology|April 9, 2010
Safety and changes in plasma and cerebrospinal fluid amyloid beta after a single administration of an amyloid beta monoclonal antibody in subjects with Alzheimer diseaseEric R Siemers, Stuart Friedrich, Robert A Dean, et al.Clinical Neuropharmacology|April 14, 2010
Treatment of benign essential blepharospasm with finasteride: a case reportMarco Bortolato, Antonino Cannas, Paolo Solla, et al.Pageof 236